LOGIN  |  REGISTER
Viking Therapeutics
Chimerix

Universal Health Services To Present At March Healthcare Conferences

February 21, 2024 | Last Trade: US$170.75 2.91 -1.68

KING OF PRUSSIA, Pa., Feb. 21, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President, and Chief Financial Officer will present at the following conferences:

Monday, March 4, 2024 at 9:50am (ET), at the TD Cowen 44th Annual Health Care Conference in Boston, MA

Tuesday, March 12, 2024 at 1:05pm (ET) at the Barclays 26th Annual Global Healthcare Conference in Miami Beach, FL.

Live audio webcasts of the presentations will be available on the Company's website (www.uhs.com). For those unable to listen to the live webcast, replays of the presentations will be available on the Company's website for 90 days following the conferences.

Universal Health Services, Inc. is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico, and the United Kingdom. 

Chimerix

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page